Scientific Program - Sunday 12 May
| Sunday 12 April, 2019 | |
|
HALL A
|
|
| 09:00-10:30 Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:00 10:00-10:15 10:15-10:30 |
Session 7 | Therapeutic Target and New Options in Diabetes Wang Yangang, China, Su Benli, China and Ralph DeFronzo, USA Should we change the A1C target in newly diagnosed patients? Asia: Zhu Dalong, China Rest of the World: Paolo Pozzilli, Italy Discussion Will dual agnostics (GLP1/Glucagon) provide the pharmalogic treatment for obesity and diabetes? Asia: Guo Lixin, China Rest of the World: Ralph DeFronzo, USA Discussion |
|
HALL B
|
|
|
09:00-10:30
Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:00 10:00-10:15 10:15-10:30 |
Session 8 | Benefits of Body Weight Control
Wang Weiqing, China, Li Yanbing, China and Abdelmajid Chraibi, Morocco
Does non bariatric reduction in weight improve CVO in T2D patients? Asia: Sou Dajin, China Rest of the World: Luc Van Gaal, Belgium Discussion Should we reduce weight in elderly T2D patients? Asia: Shi Yongquan, China Rest of the World: Abdelmajid Chraibi, Morocco Discussion |
|
HALL C
|
|
|
09:00-10:30
Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:00 10:00-10:15 10:15-10:30 |
Session 9 | Monitoring Blood Pressure and LDL
Peng Yongde, China, Chen Bing, China and Ehud Grossman, Israel Should we constantly monitor 24 b/p in patients with hypertension? Asia: Shi Lixin, China Rest of the World: Ehud Grossman, Israel Discussion Is LDL still the best lipid predictor for cardiovascular patients? Asia: Yan Li, China Rest of the World: Domenico Accili, USA Discussion |
|
10:30-10:50
|
VISIT EXHIBITS & COFFEE BREAK
|
| 10:50-11:50 | INDUSTRY SPONSORED SYMPOSIA J-L |
| 11:50-12:00 | LUNCH BOX PICK UP |
| 12:00-13:00 | INDUSTRY SPONSORED SYMPOSIA M-O |
|
HALL A
|
|
|
13:00-14:30
Chairs: 13:00-13:15 13:15-13:30 13:30-13:45 13:45-14:00 14:00-14:15 14:15-14:30 |
Session 10 | Preservation of Beta Cell Funtion and Reverse of Diabetes
Xhang Qiao, China, Shan Zhongyan, China and Ralph DeFronzo, USA Is beta cell preservation feasible in type 2 diabetes? Asia: Wang Guang, China Rest of the World: Antonio Ceriello, Italy Discussion Is diabetes reversible or not? Asia: Hong Jie, China Rest of the World: Ralph DeFronzo, USA Discussion |
|
HALL B
|
|
|
13:00-14:30
Chairs: 13:00-13:15 13:15-13:30 13:30-13:45 13:45-14:00 14:00-14:15 14:15-14:30 |
Session 11 | Controversies of Antidiabetic Therapy
Gu Wei, China, Tang Xulei, China and Philip Home, UK Should we turn to new therapies in most T2D despite the cost? Asia: Ji Linong, China Rest of the World: Eberhard Standl, Germany Discussion Is Insulin the best injectable therapy? Asia: Ji Qiuhe, China No: Abdelmajid Chraibi, Morocco Discussion |
|
HALL C |
|
| 13:00-14:30 Chairs: 13:00-13:15 13:15-13:30 13:30-13:45 13:45-14:00 14:00-14:15 14:15-14:30 |
Session 12 | The Goal of Antihypertensive therapy and restriction of sodium Hong Tianpei, China, Wang Guixia, China and Domenico Accili, USA Should we aim at blood pressure <130 in diabetic subjects? Yes: Ehud Grossman, Israel No: Bi Yufang, China Discussion Is sodium restriction effective for lowering blood pressure? Asia: Zhao Wenhua, China Rest of the World: Ehud Grossman, Israel Discussion |
| 14:30-14:45 | VISIT EXHIBITS & COFFEE BREAK |
|
PLENARY HALL
|
|
|
14:45-15:15
Chair: |
Session 13 | The Importance of Triglyceride Management in Type 2 Diabetic Patients
Wang Weiqing, China Speaker: Ji Qiuhe, China |
|
PLENARY HALL
|
|
|
15:15-16:45
Chair: |
Session 14 | CREDENCE Study Share
Wang Weiqing, China Speaker: Ji Linong, China |
|
PLENARY HALL |
|
| 16:45-17:45 Chair: |
Closing Session | How to Submit a Paper Ning Guang, China Speaker: Richard Donnelly, UK - Editor in Chief, Diabeters, Obesity and Metabolism |
|
PLENARY HALL |
|
| 17:45-18:05 Chairs: |
Closing Session | Key Note Lecture Ning Guang, China and Itamar Raz, Israel Diabetes prevention and early treatment: Ralph DeFronzo, USA |
| 18:05-18:15 | Closing Ceremony |
